CORVOSAN
CORVOSAN
Discontinued
DIN Number
00245755
Drug Class
Human
Market Date
Dec 31, 1972
Company
HC
dr reckeweg canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00245755
AIG Number0704396001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (7)
ARSENIC TRIOXIDEActive
Strength: 6 X / X
Monograph: ARSENIC TRIOXIDE
CACTUS GRANDIFLORUSActive
Strength: 2 X / X
Monograph: CACTUS GRANDIFLORUS
DIGITALISActive
Strength: 2 X / X
Monograph: DIGITALIS
HAWTHORNActive
Strength: 800 MG / X
Monograph: HAWTHORN
KALMIA LATIFOLIAActive
Strength: 3 X / X
Monograph: KALMIA LATIFOLIA
PHOSPHORUSActive
Strength: 5 X / X
Monograph: PHOSPHORUS
STROPHANTHUSActive
Strength: 2 X / X
Monograph: STROPHANTHUS